![Shao Kang Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shao Kang Wang
Director Ejecutivo en Infervision Medical Technology Co., Ltd. .
Perfil
Shao Kang Wang is currently the Executive Director & General Manager at Infervision Medical Technology Co., Ltd.
and a Member-Supervisory Board at Shanghai Infervision Biotechnology Co. Ltd.
He graduated from The University of Chicago in 2012 with a graduate degree and from Beijing Institute of Technology in 2010 with an undergraduate degree.
Cargos activos de Shao Kang Wang
Empresas | Cargo | Inicio |
---|---|---|
Infervision Medical Technology Co., Ltd.
![]() Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | Director Ejecutivo | 05/01/2016 |
Shanghai Infervision Biotechnology Co. Ltd. | Director/Miembro de la Junta | 01/01/2020 |
Formación de Shao Kang Wang.
The University of Chicago | Graduate Degree |
Beijing Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Infervision Medical Technology Co., Ltd.
![]() Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | Technology Services |
Shanghai Infervision Biotechnology Co. Ltd. |
- Bolsa de valores
- Insiders
- Shao Kang Wang